Published online May 2, 2005
PEDIATRICS Vol. 115 No. 5 May 2005, pp. e594-e599 (doi:10.1542/peds.2004-2057)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bascom, S.
Right arrow Articles by Greenblatt, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bascom, S.
Right arrow Articles by Greenblatt, J.
Related Collections
Right arrow Infectious Disease & Immunity
Right arrowRelated AAP Red Book topics:
Hepatitis B
Rubella

ELECTRONIC ARTICLE

Assessment of Perinatal Hepatitis B and Rubella Prevention in New Hampshire Delivery Hospitals

Susan Bascom, BSN, Stephanie Miller, MPH and Jesse Greenblatt, MD, MPH

From the New Hampshire Department of Health and Human Services, Division of Public Health Services, Concord, New Hampshire

Objective. To evaluate current performance on recommended perinatal hepatitis B and rubella prevention practices in New Hampshire.

Methods. Data were extracted from 2021 paired mother-infant records for the year 2000 birth cohort in New Hampshire's 25 delivery hospitals. Assessment was done on the following: prenatal screening for hepatitis B and rubella, administration of the hepatitis B vaccine birth dose to all infants, administration of hepatitis B immune globulin to infants who were born to hepatitis B surface antigen-positive mothers, rubella immunity, and administration of in-hospital postpartum rubella vaccine to rubella nonimmune women.

Results. Prenatal screening rates for hepatitis B (98.8%) and rubella (99.4%) were high. Hepatitis B vaccine birth dose was administered to 76.2% of all infants. All infants who were born to hepatitis B surface antigen-positive mothers also received hepatitis B immune globulin. Multivariate logistic regression showed that the month of delivery and infant birth weight were independent predictors of hepatitis B vaccination. The proportion of infants who were vaccinated in January and February 2000 (48.5% and 67.5%, respectively) was less than any other months, whereas the proportion who were vaccinated in December 2000 (88.2%) was the highest. Women who were born between 1971 and 1975 had the highest rate of rubella nonimmunity (9.5%). In-hospital postpartum rubella vaccine administration was documented for 75.6% of nonimmune women.

Conclusion. This study documents good compliance in New Hampshire's birthing hospitals with national guidelines for perinatal hepatitis B and rubella prevention and highlights potential areas for improvement.

Key Words: hepatitis B vaccine • hepatitis B surface antigen • rubella • rubella vaccine • postpartum • congenital rubella syndrome

Abbreviations: HBV, hepatitis B virus • ACIP, Advisory Committee on Immunization Practices • AAP, American Academy of Pediatrics • HBsAg, hepatitis B surface antigen • HBIG, hepatitis B immune globulin • CRS, congenital rubella syndrome • NH DHHS, New Hampshire Department of Health and Human Services • CI, confidence interval

Accepted Nov 30, 2004.




This article has been cited by other articles:


Home page
 Epidemiol RevHome page
J. L. Robinson, B. E. Lee, J. K. Preiksaitis, S. Plitt, and G. A. Tipples
Prevention of Congenital Rubella Syndrome--What Makes Sense in 2006?
Epidemiol. Rev., August 1, 2006; 28(1): 81 - 87.
[Abstract] [Full Text] [PDF]